2000
DOI: 10.1006/jmbi.2000.3650
|View full text |Cite
|
Sign up to set email alerts
|

Direct visualisation of the β-sheet structure of synthetic Alzheimer’s amyloid 1 1Edited by F. E. Cohen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
117
0

Year Published

2001
2001
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 173 publications
(123 citation statements)
references
References 37 publications
6
117
0
Order By: Relevance
“…This result is similar to the previous results by Liu et al [12], which indicated that residues 17-20 and 30-35 were the important regions for promoting Ab aggregation. The formation of b-sheet conformation has been proposed to be the key step for Ab aggregation [22,24], however, the propensity to form bsheets by the truncated Ab peptides did not fully correspond to the neurotoxicity and aggregative ability hierarchy, as the 25-35 truncated peptides adopted a greater proportion of bsheets than the other truncated peptides, including the 36-40 truncated Ab peptides. Besides, the IC 50 value of Ab17-35, which lacks the N-terminal residues 1-16, is $300 lM that is higher than those of the 17-21, 22-24 and 25-35 truncated Ab peptides.…”
Section: Discussionmentioning
confidence: 99%
“…This result is similar to the previous results by Liu et al [12], which indicated that residues 17-20 and 30-35 were the important regions for promoting Ab aggregation. The formation of b-sheet conformation has been proposed to be the key step for Ab aggregation [22,24], however, the propensity to form bsheets by the truncated Ab peptides did not fully correspond to the neurotoxicity and aggregative ability hierarchy, as the 25-35 truncated peptides adopted a greater proportion of bsheets than the other truncated peptides, including the 36-40 truncated Ab peptides. Besides, the IC 50 value of Ab17-35, which lacks the N-terminal residues 1-16, is $300 lM that is higher than those of the 17-21, 22-24 and 25-35 truncated Ab peptides.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, conformational changes in ␤-amyloid (A␤) in Alzheimer disease and ␣-synuclein in Parkinson disease lead to the formation of abnormal oligomers and amyloid fibrils (8). Similar to A␤ and ␣-synuclein, GAPDH is also amyloidogenic (9 -14).…”
Section: Glyceraldehyde-3-phosphate Dehydrogenase (Gapdh)mentioning
confidence: 99%
“…From the standpoint of molecular structure, the defining feature of an amyloid fibril is the presence of cross-β supramolecular structure, meaning that the β-sheets within the fibril are formed by β-strand segments that run approximately perpendicular to the long axis of the fibril and are linked by hydrogen bonds that run approximately parallel to this axis (11)(12)(13). Although determination of the molecular structures of amyloid fibrils is made difficult by their inherent noncrystallinity and insolubility, techniques such as solid state nuclear magnetic resonance (NMR) (12,(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33), electron paramagnetic resonance (EPR) (34)(35)(36), electron microscopy (37)(38)(39)(40)(41)(42)(43), hydrogen/deuterium exchange (29,(44)(45)(46)(47), scanning mutagenesis (48), chemical crosslinking (27,49,50), and x-ray diffraction of amyloid-like crystals …”
mentioning
confidence: 99%